- OCT 5, 2018 - Mass General Research Institute BlogResQFoam Study Seeks Feedback on Clinical Trial for Trauma Patients
For the next few months, King and his colleagues are reaching out to the community to share information about the clinical trial. “Part of this process is establishing a dialogue with the community and vetting what we think we have already figured out,” King says.
- JUL 11, 2018 - CBS NewsFDA approves clinical trial for potentially life-saving trauma foam
The FDA has approved the use of a potentially lifesaving foam on patients in a clinical trial at a Boston hospital
- JUL 6, 2017 - Medical Training MagazineThis ResQFoam is Going to Save the Military Countless Lives
Arsenal Medical has developed a foam system, called ResQFoam™, is designed to control acute hemorrhage. The way ResQFoam works is by injecting two liquid polymers, which together combine to create a foam. This foam quickly expands though actively flowing blood to compresses the injury and control bleeding. Upon undergoing surgery, the material is removed by the surgeon.
- JUN 7, 2017 - Task & PurposeThe Army Is Looking Into Expanding-Foam Kits To Stop Internal Bleeding
From the enterprise that brought humanity triage, ligatures, and ambulances comes the next big thing in life-saving medical technology: a futuristic substance capable of stopping internal bleeding on a battlefield.
- JUN 5, 2017U.S. FDA grants Arsenal Medical investigational device exemption approval to conduct clinical ResQFoam study
Arsenal Medical announces today that they have received unconditional IDE approval from FDA to conduct a clinical study to examine the safety and effectiveness of ResQFoamTM, a self-expanding material for the treatment of severe internal bleeding in trauma patients.
- DEC 9, 2015 - STAT NewsPentagon hopes to use foam, injected through belly button, to save bleeding soldiers
An injectable foam that snakes through the abdomen is drawing big interest from the Pentagon, which hopes to use it to control bleeding from internal injuries on the battlefield. Arsenal Medical, a medical device firm based in Watertown, Mass., on Wednesday announced it had received $14 million from the US Army Medical Research and Materiel Command.
- DEC 9, 2015Arsenal Medical Secures Funding from U.S. Army to Advance ResQFoamTM Trauma Product through Regulatory Approval
Arsenal Medical today announced that it has been granted a contract of more than $14 million to complete clinical and manufacturing development and the U.S. regulatory submission process to support product approval for its lead product candidate, ResQFoamTM.
- SEP 1, 2015 - Military MedicineResQFoam for the Treatment of Non-Compressible Hemorrhage on the Front Line
This foam treatment is envisioned as an emergency “bridge to surgery” for warfighters who would otherwise die in the field.
- JUN 1, 2015Arsenal Medical and 480 Biomedical Raise $26.5 Million in Combined Funding for Development of Novel Products to Treat Vascular Disease and Abdominal Trauma
Arsenal Medical and 480 Biomedical today announced $26.5 million in combined funding from a committed syndicate of investors to advance their respective product platforms. Arsenal Medical, a company developing novel, polymer based foam and nanofiber products, raised $16 million from Polaris Partners, North Bridge Venture Partners, and Intersouth Partners. 480 Biomedical, a clinical stage company developing innovative bioresorbable scaffold products, raised $10.5 million from the same syndicate in conjunction with a long term strategic investor. Both rounds included a conversion of debt, in addition to new equity financing.
- FEB 25, 2015 - CBS BostonWatertown Company Develops Life-Saving Trauma Foam
It looks like a simple caulking gun. But it’s no ordinary tool. “The potential impact is truly revolutionary,” says Dr. David King.
- JAN 29, 2015 - Boston MagazineResearchers Develop ‘Trauma Foam’ to Combat Internal Bleeding
The new technology may be able to extend life up to three hours.
- JAN 15, 2015 - Business WireArsenal Medical Announces Results of Novel Translational Research Study Determining Human Dose for its Trauma Foam Technology
Data supporting clinical use of foam system presented at the 28th Eastern Association for the Surgery of Trauma (EAST) Annual Scientific Assembly in Orlando, Florida
- JUN 1, 2013 - EconomistExpanding care - A new technique aims to prevent blood loss and save lives by using a rapidly expanding foam
ON OBSERVING that most injured soldiers died before receiving medical attention, Dominique-Jean Larrey, a young surgeon in Napoleon’s army, proposed installing surgical teams near the front lines. Horse-drawn carriages would whisk the wounded from the battlefield to the closest field hospital, dramatically reducing casualties. Today the whisking is done by helicopter or ambulance and the treatment on arrival is incomparably better.
- MAR 5, 2013 - WGBHWatertown's Arsenal Medical Developing Foam to Buy Time for Wounded Soldiers
About 25 percent of battlefield casualties are medically preventable, according to the Army Institute of Surgical Research. But what if there was something that could buy that wounded soldier time? One local company is working on doing just that.
- DEC 10, 2012 - Boston GlobeFoam seen as saving lives in battle with civilians next
The US military is testing the use of foam injections as a way to stanch internal bleeding of soldiers wounded on the battlefield. The technology may also eventually save the lives of civilians injured in car or other serious accidents far from a hospital emergency room. Expanding foam technology has long been a dream of the military and civilian emergency medical staff. All previous attempts have failed.
- DEC 10, 2012Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II DARPA Contract
Novel Arsenal foam technology to stabilize soldiers with severe abdominal hemorrhage, addressing major source of battlefield mortality
- MAY 3, 2021Arsenal Financial Conflict of Interest Policy
Financial Conflict of Interest Policy and Procedures